Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.4199
BATS BZX Real-Time Price
As of 1:06pm ET
 -0.0141 / -3.25%
Today’s Change
0.34
Today|||52-Week Range
3.98
-73.76%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.43
Today’s open0.43
Day’s range0.42 - 0.43
Volume525,128
Average volume (3 months)1,854,436
Market cap$24.8M
Dividend yield--
Data as of 12:53pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+68.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book8.18

Competitors

 Today’s
change
Today’s
% change
ENUMEnumeral Biomedical ...-0.04-8.67%
CANFCan Fite Biopharma L...-0.02-1.01%
--Cell Source Inc0.000.00%
CBMXCombiMatrix Corp+0.11+7.79%
Data as of 12:48pm ET, 07/30/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts